Keywords: pfizer, gets, euro, ok, cox-2, blocker, bextra

Pfizer gets Euro OK for COX-2 blocker Bextra

Article | 26 May 2003

Print This

Pfizer has been granted approval to market its new COX-2 inhibitor Bextra (valdecoxib) in the European Union. The drug, which ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in